This leads to misdiagnosis and the use of inadequate treatments, such as oral antidiabetics in a patient with T1D or high doses of insulin instead of the administration of oral antidiabetics in some patients with T2D or MODY. This evidence concerns the gene INS and type 2 diabetes mellitus.